(Total Views: 443)
Posted On: 02/13/2017 12:12:25 PM
Post# of 35
CYDY (and RXMD) are now serious investments with extreme long term potential (of course it was nice to initially flip a little from bottom up but these times are past)
DRNK is a crazy situation, wild card
To CYDY: as a scientist and looking at the recent rushed but very clean publication just in time for the upcoming conference (and meeting with GILEAD) I believe it might very well be finally sold (prob to gilead). Nice SS and few warrants, so I'd say if I buyout offer comes the bid will be, given the desperation to find new non toxic HIV treatments, the market value should be at least 4B (thats $13+ per share, so I bought some at 72 cents last week)!
DRNK is a crazy situation, wild card
To CYDY: as a scientist and looking at the recent rushed but very clean publication just in time for the upcoming conference (and meeting with GILEAD) I believe it might very well be finally sold (prob to gilead). Nice SS and few warrants, so I'd say if I buyout offer comes the bid will be, given the desperation to find new non toxic HIV treatments, the market value should be at least 4B (thats $13+ per share, so I bought some at 72 cents last week)!
(0)
(0)
